Dr. Yoon on Immunotherapy in Gastric Cancer – OncLive
|
Dr. Yoon on Immunotherapy in Gastric Cancer
OncLive Harry H. Yoon, MD, associate professor of oncology, Mayo Clinic, discusses the benefits demonstrated with nivolumab (Opdivo) and pembrolizumab (Keytruda) for patients with gastric cancer. The degree of benefit for nivolumab is higher than what has been … |
